Navigation Links
A step toward tissue-engineered heart structures for children

Infants and children receiving artificial heart-valve replacements face several repeat operations as they grow, since the since the replacements become too small and must be traded for bigger ones. Researchers at Childrens Hospital Boston have now developed a solution: living, growing valves created in the lab from a patients own cells.

In a special issue of Circulation published September 11, they describe making pulmonary valves through tissue engineering. These valves, which provide one-way blood flow from the hearts right ventricle into the pulmonary artery, are often malformed in congenital heart disease, putting an extra burden on the heart.

The heart valve is a complex organ, says Virna Sales, MD, a researcher in Childrens Department of Cardiac Surgery and the studys first author. It must open and close synchronously, withstand pressure, and be pliable and elastic. We are one of the few labs in the U.S. thats attempting to make heart valves through tissue engineering. We hope these could just be implanted in a child just once, instead of the many heart operations most children have to go through as they get older.

The researchers, led by Sales and senior investigator John Mayer, MD in Childrens Department of Cardiac Surgery, first isolated endothelial progenitor cells (precursors of the cells that line blood vessel walls) from the blood of laboratory animals. They then seeded the cells onto tiny, valve-shaped biodegradable molds and pre-coated with proteins found in the natural matrix that surrounds and supports cells.

Experimenting with different matrix proteins and growth factors, they were able to make pulmonary valve leaflets that had the right mechanical properties sturdy yet pliable. Tests showed the original cells had differentiated to form both endothelial cells and smooth-muscle-like cells and added to the surrounding matrix to hold them together.

With grants from the American Heart Association and the Cambridge, Mass.-based Center for Integration of Medicine and Innovative Technology (CIMIT), Sales is now refining the lab-grown valves by exposing them to mechanical stress in a bioreactor. She is also using a cardiac jelly a cushiony material rich in matrix components and growth factors to encourage cells to differentiate and form a heart valve on their own, with only minimal reliance on an artificial scaffold. I would like to mimic what really happens in the embryo what Mother Nature does, she says. The next step would be to implant the living valves into animals.

Sales and surgical research fellow Bret Mettler, MD, have already used tiny tissue-engineered patches in sheep to rebuild a portion of the pulmonary artery an area that often needs augmentation in patients with congenital heart disease. Eventually, Sales hopes to use tissue-engineering techniques to create living stents for adults with atherosclerosis.


Contact: Anna Gonski
Children's Hospital Boston

Related biology news :

1. Towards precise classification of cancers based on robust gene functional expression profiles
2. Unchecked DNA replication drives earliest steps toward cancer
3. Virologists make major step towards understanding the process of HIV infection
4. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
5. Cats indifference towards sugar explained
6. A step toward the $1,000 personal genome using readily available lab equipment
7. Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research
8. A new step towards an AIDS vaccine
9. New GM mosquito sexing technique is step towards malaria control, report scientists
10. Novel method reveals how menthol discovery could point towards new or improved pain therapies
11. Scientists make first step towards holy grail of crystallography
Post Your Comments:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended September 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of iCo ... value enriching for this clinical program, but also ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide ... Carolina , today announced that the company has set a ... a 391% quarter on quarter growth posted for Q3 of 2014 ... and Mexico , with the establishment of ... December 2015. --> United Kingdom and ...
Breaking Biology Technology: